Immunogen Enterprise Value:
476.27M for July 21, 2017Immunogen Enterprise Value Chart
Immunogen Historical Enterprise Value Data
| Data for this Date Range | |
|---|---|
| July 21, 2017 | 476.27M |
| July 20, 2017 | 497.72M |
| July 19, 2017 | 503.08M |
| July 18, 2017 | 529.88M |
| July 17, 2017 | 558.48M |
| July 14, 2017 | 577.24M |
| July 13, 2017 | 604.94M |
| July 12, 2017 | 588.85M |
| July 11, 2017 | 579.92M |
| July 10, 2017 | 628.17M |
| July 7, 2017 | 661.23M |
| July 6, 2017 | 638.89M |
| July 5, 2017 | 622.81M |
| July 3, 2017 | 579.03M |
| June 30, 2017 | 605.83M |
| June 29, 2017 | 615.66M |
| June 28, 2017 | 596.00M |
| June 27, 2017 | 554.90M |
| June 26, 2017 | 579.92M |
| June 23, 2017 | 512.01M |
| June 22, 2017 | 490.57M |
| June 21, 2017 | 508.44M |
| June 20, 2017 | 454.83M |
| June 19, 2017 | 409.26M |
| June 16, 2017 | 379.78M |
| June 15, 2017 | 375.31M |
| June 14, 2017 | 391.39M |
| June 13, 2017 | 385.14M |
| June 12, 2017 | 360.12M |
| June 9, 2017 | 362.80M |
| June 8, 2017 | 386.03M |
| June 7, 2017 | 375.31M |
| June 6, 2017 | 397.65M |
| June 5, 2017 | 421.77M |
| June 2, 2017 | 415.52M |
| June 1, 2017 | 396.75M |
| May 31, 2017 | 382.46M |
| May 30, 2017 | 406.14M |
| May 26, 2017 | 392.29M |
| May 25, 2017 | 423.56M |
| May 24, 2017 | 425.35M |
| May 23, 2017 | 415.52M |
| May 22, 2017 | 431.60M |
| May 19, 2017 | 439.64M |
| May 18, 2017 | 453.04M |
| May 17, 2017 | 393.18M |
| May 16, 2017 | 404.80M |
| May 15, 2017 | 377.99M |
| May 12, 2017 | 336.89M |
| May 11, 2017 | 325.28M |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
IMGN Enterprise Value Benchmarks
| Companies | |
|---|---|
| Egalet | 77.81M |
| Ocular Therapeutix | 132.41M |
| Calithera Biosciences | 393.50M |
IMGN Enterprise Value Range, Past 5 Years
| Minimum | 21.62M | Jan 03 2017 |
| Maximum | 1.472B | Jul 12 2013 |
| Average | 736.13M |
IMGN Enterprise Value Excel Add-In Codes
- Metric Code: enterprise_value
- Latest data point: =YCP("IMGN", "enterprise_value")
- Last 5 data points: =YCS("IMGN", "enterprise_value", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
IMGN News
Business Wire 07/14 08:00 ET
MT Newswires 07/06 06:44 ET
